Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Silexion Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
Galapagos Receives Transparency Notification from Bank of America
-
ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting
-
Auburn National Bancorporation Authorizes Stock Repurchase Program
-
Stardust Power Reports Preliminary 2025 Results and Highlights Development Progress at Muskogee Lithium Refinery
-
ROHM has Introduced Reference Designs for Three-Phase Inverters Featuring New SiC Power Modules
-
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
-
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
-
What Should Multi-Unit Restaurant Operators Look for When Switching POS Systems? Lavu Publishes 2026 Buyer’s Guide
-
Star Equity Holdings Reports 2025 Fourth Quarter and Full-Year Results
-
Caring for the Body, PLLC Launches Physician-Led Re-Think Aging Platform to Advance a New Era of Cognitive Decline Prevention and Longevity Care
-
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026
-
Greystone Housing Impact Investors LP Schedules Fourth Quarter 2025 Earnings Conference Call and Issues Investor Schedule K-1s
-
Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting
-
Mr. Rooter Plumbing of North Miami Beach Surpasses 100 Google Reviews with 5-Star Rating
-
Greystone Provides $46 Million Bridge-to-HUD Loan for Seniors Housing Portfolio in Ohio
-
Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
-
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial
-
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival
-
Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA
-
Sportradar to Participate in the 38th Annual Roth Conference
-
Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting
-
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026
-
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
-
Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days
-
TransAlta Corporation Announces Conversion Results for Series A and B Preferred Shares
-
BlossomHill Therapeutics Unveils New Pan-KRAS Inhibitor Programs and Announces Upcoming Presentations at AACR Annual Meeting 2026
-
Molecular Partners to Hold Three Poster Presentations at AACR 2026
-
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Akari Therapeutics Announces ADS Ratio Change
-
Parsons Announces New Chief Human Resources Officer
-
UMH PROPERTIES, INC. PUBLISHES ITS 2025 ANNUAL REPORT
-
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
-
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
-
Enara Bio to Unveil First‑in‑Class DARKFOX‑Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential for Solid Tumor Immunotherapy
-
Evaxion to present new data at AACR Annual Meeting
-
Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting
-
NNIT A/S: New CEO to lead NNIT into its next phase of growth
-
Super League Sets Fourth Quarter and Full Year 2025 Earnings Date, March 27, 2026
-
Fold Holdings, Inc. (NASDAQ: FLD) Announces Fourth Quarter and Full Year 2025 Results
-
Ocean Power Technologies, Inc. Announces Third Quarter Fiscal 2026 Results
-
Sportsman's Warehouse Holdings, Inc. Schedules Fourth Quarter and Full-Year 2025 Earnings Conference Call
-
Waterstone Financial Raises Quarterly Cash Dividend by 13.3%
-
Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates
-
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
-
Dave & Buster’s Entertainment, Inc. to Report Fourth Quarter and Fiscal Year End 2025 Financial Results on March 31, 2026
-
Orion Group Holdings, Inc. Announces Retirement of Two Board Members and Decrease in Board Size
-
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
-
American Coastal Insurance Corporation Announces the Completion of $5 Million in Common Stock Share Repurchases
-
Comscore Reports Fourth Quarter and Full Year 2025 Results

